Effect of iodine-125 radioparticle implantation therapy on quality of life in lung cancer patients with chemotherapy
-
摘要: 目的 探讨碘-125(125Ⅰ)放射性粒子植入治疗对肺癌患者生活质量的影响。 方法 选取92例中晚期肺癌患者,随机分为观察组与对照组各46例。对照组采用长春瑞滨联合顺铂方案(NP方案)进行常规化疗,观察组在常规治疗的基础上进行125Ⅰ放射性粒子植入治疗。治疗12周后,比较2组临床疗效、不良反应发生情况、生活质量水平以及预后。 结果 观察组总有效率显著高于对照组(P<0.05)。治疗后,观察组患者的认知功能、社会功能、躯体功能、情绪功能、角色功能等各项生活质量评分均显著高于对照组(P<0.05)。观察组患者不良反应总发生率显著低于对照组(P<0.05)。2组患者1年肿瘤局部控制率和1年生存率比较,差异均无统计学意义(P>0.05); 观察组患者的2年肿瘤局部控制率和2年生存率均显著高于对照组(P<0.05)。 结论 采用125Ⅰ放射性粒子植入手段治疗中晚期肺癌患者,不仅可以有效控制局部肿瘤发展,还能够降低不良反应的发生风险,改善患者的生活质量和预后。Abstract: Objective To explore the effect of iodine-125(125Ⅰ)radioparticle implantation therapy on quality of life in patients with lung cancer. Methods A total of 92 patients with middle and advanced lung cancer were selected and randomly divided into observation group(n=46)and control group(n=46). The control group received chemotherapy of vinorelbine combined with cisplatin(NP plan), while the observation group received 125Ⅰ radioparticle implantation on the basis of conventional treatment. After 12 weeks of treatment, the clinical efficacy, adverse reactions, quality of life and prognosis were compared between the two groups. Results The total effective rate of the observation group was significantly higher than that of the control group(P<0.05). After treatment, the scores of cognitive function, social function, physical function, emotional function and role function in the observation group were significantly higher than those in the control group(P<0.05). The total incidence rate of adverse reactions in the observation group was significantly lower than that in the control group(P<0.05). There were no significant differences in 1-year local control rate and 1-year survival rate between the two groups(P>0.05). The 2-year local control rate and 2-year survival rate in the observation group were significantly higher than those in the control group(P<0.05). Conclusion The 125Ⅰ radioparticle implantation therapy for patients with middle and advanced lung cancer can not only effectively control the development of local tumors, but also reduce the risk of adverse reactions and improve the quality of life and prognosis of patients.
-
Keywords:
- iodine-125 /
- radioactive particle /
- lung cancer /
- implantation therapy /
- quality of life /
- chemotherapy
-
-
霍彬, 王磊, 王海涛, 等. 模板联合肋骨钻孔技术辅助放射性粒子植入治疗肺癌的可行性[J]. 山东大学学报: 医学版, 2017, 55(2): 26-31. 韩明勇, 霍彬, 张颖, 等. CT联合模板引导放射性粒子植入治疗肺癌技术流程[J]. 山东大学学报: 医学版, 2017, 55(2): 14-20. Liu G H, Wang C B, Mingyan M Y. Mechanism and prospect of radiotherapy combined with apotatinib in the treatment of non-small cell lung cancer[J]. Chin J Lung Cancer, 2017, 20(12): 847-851.
李妮, 邓泽虎, 田福华. 放射性碘-125粒子植入联合紫杉醇治疗非小细胞肺癌的随访研究[J]. 重庆医学, 2016, 45(21): 2929-2932. De Ruysscher D, Faivre-Finn C, Moeller D, et al. European Organization for Research and Treatment of Cancer(EORTC)recommendations for planning and delivery of high-dose, high precision radiotherapy for lung cancer[J]. Radiother Oncol, 2017, 124(1): 1-10.
柴树德. 我国放射性粒子植入治疗支气管肺癌现状与技术创新[J]. 山东大学学报: 医学版, 2017, 55(2): 4-7. 刘亚, 吕维富, 成德雷, 等. 静脉化疗联合125Ⅰ放射性粒子植入治疗中晚期非小细胞肺癌的疗效评价[J]. 介入放射学杂志, 2018, 27(10): 966-971. Mao Y, Yang X Y, Li M, et al. Treating cancerous large airway Stenosis with staging radioactive particle implantation guided by computed tomography and fiber bronchoscopy: a clinical study[J]. World J Surg Oncol, 2017, 15(1): 149-156.
姜红千, 杨海涛, 李冬梅, 等. 125I放射性粒子治疗非小细胞肺癌患者疗效评价[J]. 中国公共卫生, 2018, 34(12): 1684-1686. Lu G X, Zhang G X, Zhang C X, et al. A study of 131iodine-labeling of histamine-indomethacin: its in vivo therapeutic effect and anti-tumor mechanisms in Lewis-bearing lung cancer[J]. Radiat Oncol, 2013, 8: 74-83.
山东省医师协会综合介入医师分会, 山东省抗癌协会肿瘤介入学分会. 放射性125Ⅰ粒子植入治疗肺恶性肿瘤山东专家共识(2015, 济南)[J]. 山东医药, 2016, 56(6): 1-3. 廖江荣, 王黔宇, 姜蓬. 经支气管镜植入放射性125Ⅰ粒子治疗中央型肺癌合并肺不张的疗效观察[J]. 天津医药, 2018, 46(3): 277-279. 龚正, 张彩云, 王艳华, 等. 气道内金属支架置入术联合放射性粒子植入对比放疗治疗肺癌气道狭窄的临床研究[J]. 介入放射学杂志, 2016, 25(10): 870-873. Li W, Dan G, Jiang J Q, et al. Repeated iodine-125 seed implantations combined with external beam radiotherapy for the treatment of locally recurrent or metastatic stage Ⅲ/Ⅳnon-small cell lung cancer: a retrospective study[J]. Radiat Oncol, 2016, 11(1): 119-125.
郭国华, 宋彬, 朱传奇, 等. 经超声支气管镜125Ⅰ粒子植入联合全身化疗治疗晚期非小细胞肺癌大气道狭窄临床效果分析[J]. 介入放射学杂志, 2019, 28(6): 542-546. 曾奕明, 林燕萍. 放射性125Ⅰ粒子植入局部治疗支气管肺癌[J]. 山东大学学报: 医学版, 2017, 55(4): 1-6. Guckenberger M, Andratschke N, Dieckmann K, et al. ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer[J]. Radiother Oncol, 2017, 124(1): 11-17.
孙玉贞, 秦利春, 张新枝, 等. 放射性粒子植入治疗肺癌患者的生活质量调查及护理干预[J]. 实用临床医药杂志, 2018, 22(2): 35-38. -
期刊类型引用(8)
1. 钱秋然，张圆圆，王杰平. 探讨CT引导下放射性碘125粒子组织间植入对复发性卵巢癌的近期治疗效果. 临床研究. 2025(02): 18-21 . 
百度学术
2. 王洁，尤国美，罗君，陈羚，吕展杨. ~(125)I粒子治疗患者心理一致感在自我感受负担和生活质量的中介作用. 介入放射学杂志. 2024(12): 1349-1354 . 百度学术
3. 郭霞，林秀如，雷晓娟. 延续性护理在放射性碘125粒子植入患者院外防护的应用. 医学理论与实践. 2023(04): 695-697 . 百度学术
4. 徐燕，朱春云. 碘-125植入术后病区护理人员外周血象监测及防护. 实用临床医药杂志. 2023(13): 123-126 . 本站查看
5. 鲁雪妮，宋永春，王妮妮，丁蕊娜，王岐，杨爱民. ~(125)I粒子植入术后患者周围的辐射监测及其意义. 医学信息. 2021(04): 171-173 . 百度学术
6. 吴峰，徐红卫，郭辉，权红军，郭彦伟. CT引导下氩氦刀联合放射性粒子植入治疗非小细胞肺癌的临床疗效. 中华老年医学杂志. 2021(02): 197-202 . 百度学术
7. 单卉，陈德平，李卫平，李信，候海文. CT引导下微波消融与粒子植入治疗非小细胞肺癌的疗效分析. 南昌大学学报(医学版). 2021(04): 40-43 . 百度学术
8. 蒋婷. 经气管镜碘125粒子植入联合化疗治疗晚期中央型肺癌临床疗效探讨. 基层医学论坛. 2020(34): 4927-4929 . 百度学术
其他类型引用(0)
计量
- 文章访问数: 516
- HTML全文浏览量: 81
- PDF下载量: 13
- 被引次数: 8
下载:
苏公网安备 32100302010246号